ArticleBMC public health2025
Exploratory analysis of the economically justifiable price of reslizumab for asthma severe in Colombia.
Jefferson Antonio Buendía et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it